AXA1125 remains the most advanced product to help patients experiencing fatigue post acute COVID-19 The Company continues to pursue a strategic...
0001633070 false 0001633070 2023-06-23 2023-06-23 iso4217:USD xbrli:shares...
2023Q1false0001633070--12-3100016330702023-01-012023-03-3100016330702023-04-28xbrli:shares00016330702023-03-31iso4217:USD00016330702022-12-31iso421...
0001633070FALSEP.O. Box 1270LittletonMassachusetts00016330702023-05-042023-05-04UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C...
Long COVID Phase 2b/3 clinical trial may proceed under U.S. Investigational New Drug application MHRA guidance aligns on key measurements for a...
Dr. Lucy E.M. Finnigan will present on the Phase 2a clinical trial of AXA1125 in Long COVID Fatigue on April 18 Dr. Finnigan will also report on...
0001633070 false 0001633070 2023-04-03 2023-04-03 iso4217:USD xbrli:shares...
2022FYfalse000163307000016330702022-01-012022-12-3100016330702022-06-30iso4217:USD00016330702023-03-28xbrli:shar...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads